StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3012% below fair value
$0.95+0.06 (+7.26%)

Close on Nov 18, 2026Market cap $94.80MP/E –Yield –

Stereotaxis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Stereotaxis's revenue for the twelve months ending Jun 30, 2026 was $30.07M, down 5.5% year over year. For fiscal 2025 it was $32.38M, up 20.3% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is $54.05M in fiscal 2010.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$32.38M+20.3%
FY2024Dec 31, 2024$26.92M+0.5%
FY2023Dec 31, 2023$26.77M-4.9%
FY2022Dec 31, 2022$28.15M-19.6%
FY2021Dec 31, 2021$35.02M+31.5%
FY2020Dec 31, 2020$26.63M-7.9%
FY2019Dec 31, 2019$28.90M-1.5%
FY2018Dec 31, 2018$29.35M-5.8%
FY2017Dec 31, 2017$31.14M-3.2%
FY2016Dec 31, 2016$32.16M-14.6%
FY2015Dec 31, 2015$37.67M+7.6%
FY2014Dec 31, 2014$35.01M-7.9%
FY2013Dec 31, 2013$38.03M-18.3%
FY2012Dec 31, 2012$46.56M+10.9%
FY2011Dec 31, 2011$41.99M-22.3%
FY2010Dec 31, 2010$54.05M+5.7%
FY2009Dec 31, 2009$51.15M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.67M-12.8%
Q1 FY2026Mar 31, 2026$6.29M-15.8%
Q4 FY2025Dec 31, 2025$8.64M+36.3%
Q3 FY2025Sep 30, 2025$7.46M-18.8%
Q2 FY2025Jun 30, 2025$8.80M+95.4%
Q1 FY2025Mar 31, 2025$7.47M+8.6%
Q4 FY2024Dec 31, 2024$6.34M+38.9%
Q3 FY2024Sep 30, 2024$9.20M+17.9%
Q2 FY2024Jun 30, 2024$4.50M-42.7%
Q1 FY2024Mar 31, 2024$6.88M+5.1%
Q4 FY2023Dec 31, 2023$4.57M-37.5%
Q3 FY2023Sep 30, 2023$7.80M+1.9%
Q2 FY2023Jun 30, 2023$7.86M+27.7%
Q1 FY2023Mar 31, 2023$6.55M-6.9%
Q4 FY2022Dec 31, 2022$7.30M-11.4%
Q3 FY2022Sep 30, 2022$7.66M-15.9%
Q2 FY2022Jun 30, 2022$6.15M-32.0%
Q1 FY2022Mar 31, 2022$7.04M-18.4%
Q4 FY2021Dec 31, 2021$8.24M+20.8%
Q3 FY2021Sep 30, 2021$9.11M+4.6%
Q2 FY2021Jun 30, 2021$9.05M+69.3%
Q1 FY2021Mar 31, 2021$8.62M+49.8%
Q4 FY2020Dec 31, 2020$6.82M-1.0%
Q3 FY2020Sep 30, 2020$8.70M+6.1%
Q2 FY2020Jun 30, 2020$5.35M-21.4%
Q1 FY2020Mar 31, 2020$5.76M-17.9%
Q4 FY2019Dec 31, 2019$6.89M-5.2%
Q3 FY2019Sep 30, 2019$8.20M+8.6%
Q2 FY2019Jun 30, 2019$6.80M-10.0%
Q1 FY2019Mar 31, 2019$7.01M+0.5%
Q4 FY2018Dec 31, 2018$7.27M-3.8%
Q3 FY2018Sep 30, 2018$7.56M-7.2%
Q2 FY2018Jun 30, 2018$7.55M-10.8%
Q1 FY2018Mar 31, 2018$6.97M-0.1%
Q4 FY2017Dec 31, 2017$7.56M+3.4%
Q3 FY2017Sep 30, 2017$8.14M-2.3%
Q2 FY2017Jun 30, 2017$8.47M–
Q1 FY2017Mar 31, 2017$6.98M–
Q4 FY2016Dec 31, 2016$7.31M–
Q3 FY2016Sep 30, 2016$8.33M–

More Stereotaxis figures

See a number that looks wrong?